SE0104421D0 - New composition - Google Patents

New composition

Info

Publication number
SE0104421D0
SE0104421D0 SE0104421A SE0104421A SE0104421D0 SE 0104421 D0 SE0104421 D0 SE 0104421D0 SE 0104421 A SE0104421 A SE 0104421A SE 0104421 A SE0104421 A SE 0104421A SE 0104421 D0 SE0104421 D0 SE 0104421D0
Authority
SE
Sweden
Prior art keywords
skin
preparation
lipophilic
components
hydrophilic components
Prior art date
Application number
SE0104421A
Other languages
English (en)
Swedish (sv)
Inventor
Paer Lindau
Original Assignee
Ponsus Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ponsus Pharma Ab filed Critical Ponsus Pharma Ab
Priority to SE0104421A priority Critical patent/SE0104421D0/xx
Publication of SE0104421D0 publication Critical patent/SE0104421D0/xx
Priority to AU2002359200A priority patent/AU2002359200A1/en
Priority to US10/499,148 priority patent/US20050049232A1/en
Priority to JP2003556032A priority patent/JP2005519887A/ja
Priority to PCT/SE2002/002421 priority patent/WO2003055454A1/en
Priority to EP02793721A priority patent/EP1463483A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
SE0104421A 2001-12-21 2001-12-21 New composition SE0104421D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0104421A SE0104421D0 (sv) 2001-12-21 2001-12-21 New composition
AU2002359200A AU2002359200A1 (en) 2001-12-21 2002-12-20 New composition
US10/499,148 US20050049232A1 (en) 2001-12-21 2002-12-20 Composition
JP2003556032A JP2005519887A (ja) 2001-12-21 2002-12-20 新規組成物
PCT/SE2002/002421 WO2003055454A1 (en) 2001-12-21 2002-12-20 New composition
EP02793721A EP1463483A1 (en) 2001-12-21 2002-12-20 New composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0104421A SE0104421D0 (sv) 2001-12-21 2001-12-21 New composition

Publications (1)

Publication Number Publication Date
SE0104421D0 true SE0104421D0 (sv) 2001-12-21

Family

ID=20286516

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0104421A SE0104421D0 (sv) 2001-12-21 2001-12-21 New composition

Country Status (6)

Country Link
US (1) US20050049232A1 (xx)
EP (1) EP1463483A1 (xx)
JP (1) JP2005519887A (xx)
AU (1) AU2002359200A1 (xx)
SE (1) SE0104421D0 (xx)
WO (1) WO2003055454A1 (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
KR100738434B1 (ko) 2005-09-13 2007-07-12 (주)아모레퍼시픽 피롤리디닐 디아미노피리미딘 옥사이드를 함유하는 화장료조성물
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
WO2008110872A2 (en) * 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
EP2115052A4 (en) * 2007-01-19 2013-01-09 Ponsus Pharma Ab UREA-FOAM
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2009101497A2 (en) * 2008-02-11 2009-08-20 Glenmark Pharmaceuticals Limited Topical pharmaceutical combination comprising minoxidil and aminexil
US20100092400A1 (en) * 2008-10-15 2010-04-15 Quinnova Pharmaceuticals, Inc. Salicylic Acid Composition
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CN102686205A (zh) 2009-10-02 2012-09-19 弗艾米克斯有限公司 局部四环素组合物
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9345720B2 (en) 2010-10-26 2016-05-24 Exeltis Usa Dermatology, Inc. Composition and method for treating wounds
WO2014087421A2 (en) 2012-12-04 2014-06-12 Dow Corning India Private Limited Stable hydrophilic medium-soluble composition and the use thereof
EP2952194B1 (en) 2013-01-31 2018-06-27 Fujifilm Corporation Emulsion composition
WO2014168193A1 (ja) * 2013-04-11 2014-10-16 大正製薬株式会社 外用組成物
JP6821916B2 (ja) * 2015-02-26 2021-01-27 大正製薬株式会社 外用組成物
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) * 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
DE3781034T2 (de) * 1986-06-13 1993-02-18 Procter & Gamble Topische pharmazeutische zubereitung mit besserer durchdringungsfaehigkeit.
AU8025787A (en) * 1986-09-12 1988-04-07 Upjohn Company, The Foams for delivery of minoxidil
US5030442A (en) * 1987-03-30 1991-07-09 Liposome Technology, Inc. Non-crystalline minoxidil composition
US4866067A (en) * 1987-12-07 1989-09-12 Ricerche De Schiena s.n.c del Dr. Michele Giuseppe Di Schiena & C. 6-piperidino-2,4-diaminopyrimidine-3-oxide salt of 3-carboxypyridine n-oxide and topical, related compositions
LU87308A1 (fr) * 1988-08-01 1990-03-13 Oreal Nouveaux derives de diamino-2,4 pyrimidine oxyde-3 et leur utilisation pour le traitement et la prevention de la chute des cheveux
DK0542802T3 (da) * 1990-08-10 1996-07-22 Upjohn Co Stimulering af hårvækst med kaliumkanalåbnere og 5alfa-reduktase-inhibitorer
FR2753378B1 (fr) * 1996-09-17 1998-11-20 Oreal Utilisation dans une composition en tant que stimulateur de tyrosinase d'au moins un derive de pyrimidine 3-oxyde, substitue en 6
SE520811C2 (sv) * 1997-01-17 2003-08-26 Ponsus Ab Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav
AU5570898A (en) 1997-01-21 1998-08-07 Nycomed Amersham Plc Labelled factor xiiia substrates
IT1298575B1 (it) 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
AUPP310798A0 (en) * 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
IL124764A0 (en) * 1998-06-04 1999-01-26 Univ Ben Gurion Topical composition for treatment of baldness
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
KR100352088B1 (ko) * 1999-06-21 2002-09-12 한미약품공업 주식회사 미녹시딜 함유 외용 에멀젼 조성물
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7442369B1 (en) * 2000-08-09 2008-10-28 Mcneil Ab Compositions of minoxidil

Also Published As

Publication number Publication date
AU2002359200A1 (en) 2003-07-15
US20050049232A1 (en) 2005-03-03
EP1463483A1 (en) 2004-10-06
WO2003055454A1 (en) 2003-07-10
JP2005519887A (ja) 2005-07-07

Similar Documents

Publication Publication Date Title
SE0104421D0 (sv) New composition
DE69827929D1 (de) Hautpflegemittel
ATE432677T1 (de) Gerät zur ablage von geflochtenen prothesen
BR0113477A (pt) Peptìdios de penetração em membranas e usos dos mesmos
WO2000030622A3 (de) Verwendung von dialkylfumaraten zur behandlung von host-versus-graft reaktionen und von autoimmunerkrankungen
EP1295893A4 (en) GINSENOSIDES FOR PROMOTING SKIN WEBERENEGENERATION
AU2003276914A1 (en) Microemulsions having a binary phase differentiability and active substance differentiability, the production thereof and their use, particularly for the topical supply of oxygen
AU7634801A (en) Three-dimensional skin model
ATE279910T1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
DE60028152D1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher Komplex von Orthokieselsäure und Prozess zur dessen Herstellung
EP1172084A3 (de) Kosmetische und dermatologische Zubereitung zur Beseitigung vom Sebum
WO2003015724A8 (fr) Substances capables de potentialiser la productivite de la laminine 5 dans des cellules epidermiques et utilisation desdites substances
WO2017159767A1 (ja) フコイダン育毛剤
AU2003296692A1 (en) Lipidic protein-transfer systems and cosmetic/dermatological use thereof
BR0009771A (pt) Utilização de derivados de bisindóis indigóides capazes de penetrarem na membrana de células
JP5259063B2 (ja) 毛髪処理剤及び毛髪処理方法
EP1681297A4 (en) INHIBITOR OF TYROSINASE ACTIVITY AND MEANS TO IMPROVE THE BLOOD OF THE FACE
JP2005232163A (ja) 脱毛促進剤、脱毛促進組成物、脱毛促進方法
DK1680067T3 (da) Sammensætning til kosmetisk behandling af aldersrelaterede dermatologiske symptomer
WO2004052331A3 (fr) Utilisation d'un extrait de miellat de coton comme ingredient acitif
KR927002996A (ko) 발모촉진용 조성물
KR19990011218A (ko) 생약 탈모 방지액
WO2001085126A3 (en) Cosmetic skin care compositions containing pulegone
JP2002241235A (ja) 発毛剤